Lipid Accumulation Product As a Predictor of Prediabetes and Diabetes: Insights From NHANES Data (1999-2018)

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2024 Nov 19

PMID 39559713

Authors

Yan Wang

Xiaolan Wang

Ling Zeng

Affiliations

Soon will be listed here.

Abstract

The study investigates the association between lipid accumulation product (LAP) and the risk of prediabetes and diabetes. LAP, a measure indicating lipid overaccumulation, is hypothesized to be a significant predictor for these conditions. This research utilizes data from the National Health and Nutrition Examination Survey (NHANES) conducted between 1999 and 2018. The study followed a structured methodology, starting with data extraction from the NHANES database. Participants' eligibility was determined based on specific inclusion and exclusion criteria, resulting in a final sample size of 24,121 individuals. LAP was calculated using established formulas for men and women. The diagnosis of prediabetes and diabetes was based on standard medical criteria, including HbA1c levels, fasting plasma glucose, and oral glucose tolerance test (OGTT) results. Covariates like demographic variables, lifestyle factors, and other health indicators were also considered. Statistical analysis involved categorizing LAP into quartiles and employing logistic regression models to examine the relationship between LAP and the risk of prediabetes and diabetes. Participants in the highest LAP quartile exhibited distinct characteristics: older age, lower education levels, more former smokers and drinkers, higher blood pressure and cholesterol levels, and greater use of medications. A positive association was observed between LAP and the incidence of prediabetes and diabetes across all models. Specifically, each 10-unit increase in LAP was linked to a 22% increase in risk. Nonlinear relationships were also explored, revealing an inflection point in the risk correlation at an LAP value of 68.1. The study concludes that LAP is a significant predictor of prediabetes and diabetes risk, with higher LAP levels correlating with increased risk. This finding underscores the potential of LAP as a useful marker in identifying individuals at higher risk for these conditions. It also highlights the importance of considering LAP in preventive health strategies.

References

Franceschi C, Campisi J . Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014; 69 Suppl 1:S4-9. DOI: 10.1093/gerona/glu057. View

Jafari A, Najafipour H, Shadkam M, Aminizadeh S . Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS). Lipids Health Dis. 2023; 22(1):169. PMC: 10552300. DOI: 10.1186/s12944-023-01932-x. View

Lyssenko V, Laakso M . Genetic screening for the risk of type 2 diabetes: worthless or valuable?. Diabetes Care. 2013; 36 Suppl 2:S120-6. PMC: 3920800. DOI: 10.2337/dcS13-2009. View

Cybulska A, Schneider-Matyka D, Wieder-Huszla S, Panczyk M, Jurczak A, Grochans E . Diagnostic markers of insulin resistance to discriminate between prediabetes and diabetes in menopausal women. Eur Rev Med Pharmacol Sci. 2023; 27(6):2453-2468. DOI: 10.26355/eurrev_202303_31779. View

Darroudi S, Soflaee S, Hosseini Z, Farmad M, Mirshafiei H, Sheikh Andalibi M . The visceral adiposity index and lipid accumulation product as predictors of cardiovascular events in normal weight subjects. Clin Nutr ESPEN. 2022; 52:190-197. DOI: 10.1016/j.clnesp.2022.10.015. View

Lin C, Li J, Wu F, Wang J, An H, Qiu H . Comparison of lipid accumulation product and visceral adiposity index with traditional obesity indices in early-onset type 2 diabetes prediction: a cross-sectional study. Diabetol Metab Syndr. 2023; 15(1):111. PMC: 10223887. DOI: 10.1186/s13098-023-01056-3. View

Ayundini G, Astrella C, Tahapary D, Soewondo P . A Systematic Review on the Association between Lipid Accumulation Product Index and Type 2 Diabetes Mellitus. J ASEAN Fed Endocr Soc. 2021; 34(1):16-20. PMC: 7784243. DOI: 10.15605/jafes.034.01.04. View

Zheng X, Zhang X, Han Y, Hu H, Cao C . Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults. Cardiovasc Diabetol. 2023; 22(1):205. PMC: 10416492. DOI: 10.1186/s12933-023-01934-0. View

Kahn H . The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2005; 29(1):151-3. DOI: 10.2337/diacare.29.1.151. View

10.

Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X . Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014; 13:146. PMC: 4209231. DOI: 10.1186/s12933-014-0146-3. View

11.

Xu M, Huang M, Qiang D, Gu J, Li Y, Pan Y . Hypertriglyceridemic Waist Phenotype and Lipid Accumulation Product: Two Comprehensive Obese Indicators of Waist Circumference and Triglyceride to Predict Type 2 Diabetes Mellitus in Chinese Population. J Diabetes Res. 2020; 2020:9157430. PMC: 7725575. DOI: 10.1155/2020/9157430. View

12.

Ross R, Neeland I, Yamashita S, Shai I, Seidell J, Magni P . Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020; 16(3):177-189. PMC: 7027970. DOI: 10.1038/s41574-019-0310-7. View

13.

Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H . Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020; 369:m997. PMC: 7186854. DOI: 10.1136/bmj.m997. View

14.

Kahn H . The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005; 5:26. PMC: 1236917. DOI: 10.1186/1471-2261-5-26. View

15.

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

16.

Ahn N, Baumeister S, Amann U, Rathmann W, Peters A, Huth C . Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes. Sci Rep. 2019; 9(1):9693. PMC: 6609728. DOI: 10.1038/s41598-019-46187-8. View

17.

Khanmohammadi S, Tavolinejad H, Aminorroaya A, Rezaie Y, Ashraf H, Vasheghani-Farahani A . Association of lipid accumulation product with type 2 diabetes mellitus, hypertension, and mortality: a systematic review and meta-analysis. J Diabetes Metab Disord. 2022; 21(2):1943-1973. PMC: 9672205. DOI: 10.1007/s40200-022-01114-z. View

18.

Wang L, Li X, Wang Z, Bancks M, Carnethon M, Greenland P . Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018. JAMA. 2021; . PMC: 8233946. DOI: 10.1001/jama.2021.9883. View

19.

Meyer T, Hostetter T . Uremia. N Engl J Med. 2007; 357(13):1316-25. DOI: 10.1056/NEJMra071313. View

20.

Deng H, Hu P, Li H, Zhou H, Wu X, Yuan M . Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study. Cardiovasc Diabetol. 2022; 21(1):212. PMC: 9571423. DOI: 10.1186/s12933-022-01660-z. View